CORPORATE REPUTATION-THE PATIENT PERSPECTIVE
2.2K views | +0 today
Follow
CORPORATE REPUTATION-THE PATIENT PERSPECTIVE
Your new post is loading...
Your new post is loading...
Rescooped by PatientView from Disruptive Digital Technology News & Views
Scoop.it!

Pharma On Instagram

Pharmaguy’s Select List of Big Pharma Companies with Corporate Instagram Accounts


Via Pharma Guy
PatientView's insight:

Pharma engaging with soical media @pharmaguy

more...
No comment yet.
Scooped by PatientView
Scoop.it!

Cancer edition: Corporate Reputation of Pharma in 2015 - the views of 280 patient groups with an interest in cancer

Cancer edition: Corporate Reputation of Pharma in 2015 - the views of 280 patient groups with an interest in cancer | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
PatientView's insight:

More on how cancer patient groups perceive pharma and patient centricity

more...
No comment yet.
Scooped by PatientView
Scoop.it!

Hepatitis edition: Corporate Reputation of Pharma in 2015 - the views of 111 patient groups with an interest in hepatitis

Hepatitis edition: Corporate Reputation of Pharma in 2015 - the views of 111 patient groups with an interest in hepatitis | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
more...
No comment yet.
Rescooped by PatientView from Pharmaguy's Insights Into Drug Industry News
Scoop.it!

Two "Unbroke Girls" & George Cluny Aim to Give J&J Its Comeuppance in New Film

Two "Unbroke Girls" & George Cluny Aim to Give J&J Its Comeuppance in New Film | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it

“Making a Murderer” filmmakers Laura Ricciardi and Moira Demos are set adapt the serialized Huffington Post article “America’s Most Admired Lawbreaker” for TV. The project is the first under a new first-look deal between Sonar Entertainment and George Clooney and Grant Heslov’s Smokehouse Pictures.

Written by journalist Steven Brill, “America’s Most Admired Lawbreaker” tells the story of a a division of pharmaceutical giant Johnson & Johnson that created a powerful antipsychotic drug and marketed it aggressively to children and the elderly, while allegedly withholding data about its terrible side effects. Johnson & Johnson agreed to pay more than $2 billion in penalties and settlements, but sold a reported $30 billion worth of the drug worldwide.

Nicki Paluga will adapt the article to series with Ricciardi and Demos, with the latter two directing. The scripted event series does not yet have an episode count.

The project and the deal with Sonar are part of a continued effort by Smokehouse to push into television. The company is already developing “Ms,” a miniseries about Gloria Steinem and the founding of Ms Magazine, at HBO, and “The Studio,” about a movie studio in the 1990’s,  Showtime.

“We couldn’t be more excited to be in business with George and Grant and their talented team at Smokehouse,” said Sonar CEO Thomas Lesinski. “Smokehouse has a stellar track record of delivering commercial and critically acclaimed content. Smokehouse will be a great partner for Sonar Entertainment, as the two companies align perfectly in our approaches to premium TV programming.”


Via Pharma Guy
more...
Pharma Guy's curator insight, June 17, 7:31 AM

Johnson and Johnson, agreed to pay $2.2 billion to the U.S. government to end civil and criminal investigations into kickbacks to pharmacists and the marketing of pharmaceuticals for off-label uses. According to an NBC News story (here), "The settlement with the company and its subsidiaries covers the marketing of schizophrenia treatment Risperdal and of heart drug Natrecor, said the source, who spoke on condition of anonymity." Also read: “Money Doesn't Make Big Pharma Accountable: Why Suing Isn't Working”; http://sco.lt/6XbVHl 

Scooped by PatientView
Scoop.it!

Drugmakers plan stronger pushback on state-level price regulation

Drugmakers plan stronger pushback on state-level price regulation | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
BioPharma
more...
No comment yet.
Scooped by PatientView
Scoop.it!

SPANISH edition: Corporate Reputation of Pharma in 2015 - the views of 108 Spanish patient groups

SPANISH edition: Corporate Reputation of Pharma in 2015 - the views of 108 Spanish patient groups | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
more...
No comment yet.
Scooped by PatientView
Scoop.it!

Winning Over Pharma Communication Challenges - DTC Perspectives

Winning Over Pharma Communication Challenges - DTC Perspectives | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
Social Media, Risk, Cross-Functional and Strategy   Renowned author and literary critic Lawrence Clark Powell said, “Write to be understood, speak to be heard, read to grow.” The idealism inherent in this statement is inspirational for the pharmaceutical industry when overcoming communication challenges. Barriers are eliminated through insightful interpretation of the written word, verbalization of …
more...
No comment yet.
Scooped by PatientView
Scoop.it!

Corporate Reputation of Pharma in 2015 (NEUROLOGICAL edition) - the views of 257 patient groups

Corporate Reputation of Pharma in 2015 (NEUROLOGICAL edition) - the views of 257 patient groups | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
PatientView's insight:

Latest corp rep from the perspective of neurological patient groups. @UCB top

more...
No comment yet.
Scooped by PatientView
Scoop.it!

Corporate Reputation of Pharma in 2015 (US EDITION) - The views of 100+ US patient groups

Corporate Reputation of Pharma in 2015 (US EDITION) - The views of 100+ US patient groups | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
PatientView's insight:

Patient groups in the US ever more angry about pricing

more...
No comment yet.
Scooped by PatientView
Scoop.it!

THE CORPORATE REPUTATION OF THE PHARMACEUTICAL INDUSTRY IN 2015

THE CORPORATE REPUTATION OF THE PHARMACEUTICAL INDUSTRY IN 2015 | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it

Conrats PRESS RELEASE The corporate reputation of the pharmaceutical industry in 2015—the patient perspective (5th edition) Report published by PatientView London, March 10th, 2016. This report is based on the findings of a PatientView November 2015-January 2016 survey exploring the views of 1,075 patient groups from 72 countries, and focusing on differing medical specialties. The report…

PatientView's insight:

Congrats to @Viiv @AbbVie @Lundbeck @janssen & @novonordisk Top 5 out of 48 say patient groups

more...
No comment yet.
Rescooped by PatientView from New pharma
Scoop.it!

Almirall's Eduardo Sanchiz and Alfonso Ugarte with their view on patient centricity to pharma - eyeforpharma Barcelona 2016

Almirall's  Eduardo Sanchiz and Alfonso Ugarte with their view on patient centricity to pharma - eyeforpharma Barcelona 2016 | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it

In these exclusive videos eyeforpharma's Paul SImms spoke with Eduardo Sanchiz and Alfonso Ugarte, resp CEO and Senior Director of Global Business Units of Almirall, on the changing pharma landscape, patient value and rewriting the business plan.



Via rob halkes
PatientView's insight:

@almirall  is featured in our new corporate rep report in March 2016  43 patient groups commenti on the company

more...
rob halkes's curator insight, February 6, 10:11 AM

Inspiring to see the leadership of Almirall speaking about their personal drives to lead their company to patient centricity.

Scooped by PatientView
Scoop.it!

Request to patient groups worldwide to input into PatientView's independent study "What is the corporate reputation of pharma in 2015 - from the patient perspective?"

Request to patient groups worldwide to input into PatientView's independent study "What is the corporate reputation of pharma in 2015 - from the patient perspective?" | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
For any queries about this study please contact: Dr Alexandra Wyke, CEO, PatientView. Email: alexwyke@patient-view.com For the 5th consecutive year, PatientView is requesting patient organisations ...
PatientView's insight:

An important tool for measure pharma's engagement with Patient Advocacy Groups

more...
No comment yet.
Scooped by PatientView
Scoop.it!

German patient groups worry most about patient safety

German patient groups worry most about patient safety | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
354 KB of files sent via WeTransfer, a free service to send big or small files from A to B
PatientView's insight:

Insight from PatientView's latest corporate reputation report on pharma in Germany - from a patient perspective

more...
No comment yet.
Scooped by PatientView
Scoop.it!

Astellas boosts pharma's rep with corporate branding push

Astellas boosts pharma's rep with corporate branding push | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
The new TV spot was developed with CNN and Edelman.
PatientView's insight:

Does corporate branding advertising work for pharma?

more...
No comment yet.
Scooped by PatientView
Scoop.it!

ConvaTec now 1st in latest 'Corporate-Reputation Survey—from the Perspective of Patient Groups Worldwide'

ConvaTec now 1st in latest 'Corporate-Reputation Survey—from the Perspective of Patient Groups Worldwide' | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
PatientView's insight:

ConvaTec now 1st in latest 'Corporate-Reputation Survey—from the Perspective of Patient Groups Worldwide'

more...
No comment yet.
Scooped by PatientView
Scoop.it!

Italian edition: Corporate Reputation of Pharma in 2015 - the views of 67 Italian patient groups

Italian edition: Corporate Reputation of Pharma in 2015 - the views of 67 Italian patient groups | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
PatientView's insight:

OUr latest analysis on the reputation of pharma in Italy

more...
No comment yet.
Scooped by PatientView
Scoop.it!

German edition: Corporate Reputation of Pharma in 2015 - the views of 60 German patient groups

German edition: Corporate Reputation of Pharma in 2015 - the views of 60 German patient groups | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
more...
No comment yet.
Scooped by PatientView
Scoop.it!

UK edition: Corporate Reputation of Pharma in 2015 - the views of 62 UK patient groups

UK edition: Corporate Reputation of Pharma in 2015 - the views of 62 UK patient groups | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
more...
No comment yet.
Scooped by PatientView
Scoop.it!

Vermont poised to become first state to require pharma to justify pricing - STAT

Vermont poised to become first state to require pharma to justify pricing - STAT | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
A bill in Vermont that would force drug firms to be more transparent about their pricing practices could be signed into law next month.
PatientView's insight:

Its inevitable

more...
No comment yet.
Scooped by PatientView
Scoop.it!

RARE DISEASE edition: Corporate Reputation of Pharma in 2015 - the views of 199 patient groups

RARE DISEASE edition: Corporate Reputation of Pharma in 2015 - the views of 199 patient groups | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
more...
No comment yet.
Scooped by PatientView
Scoop.it!

Corporate Reputation of Pharma in 2015 (European EDITION) - the views of 797 patient groups

Corporate Reputation of Pharma in 2015 (European EDITION) - the views of 797 patient groups | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
PatientView's insight:

Our European analaysis on Corp Rep of Pharma

more...
No comment yet.
Scooped by PatientView
Scoop.it!

News on DRUG PRICING from The Associated Press

News on DRUG PRICING from The Associated Press | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
PatientView's insight:

New on US pricing policy on prescription drugs

more...
No comment yet.
Scooped by PatientView
Scoop.it!

CORP REPUTATION 2016

CORP REPUTATION 2016 | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
PatientView has completed its 2015 version of the Corporate-Reputation survey (Global report to be published 10th March 2016 onwards).
PatientView's insight:

Results out March 10th for Corp Rep 2015 -From the Perspective of Over 1,000 Patient Groups - 48 companies analysed

more...
No comment yet.
Scooped by PatientView
Scoop.it!

Top 10 Most Innovative Biopharma Companies, Announced at the J.P. Morgan Healthcare Conference

Top 10 Most Innovative Biopharma Companies, Announced at the J.P. Morgan Healthcare Conference | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
Scores of leading biopharma C-suite and senior executives congregated at IDEA Pharma’s The Future of Pharma panel discussion event to hear the company announce who it believes are the top 10 most innovative and exciting companies selected from the whole of the industry, as it launches its new index - The IDEA Index.
PatientView's insight:

But not all these companies have good reputations despite being good at innovation

more...
No comment yet.
Scooped by PatientView
Scoop.it!

What 74 Scandanavian Patient Groups say about Pharma's Corporate Reputation

What 74 Scandanavian Patient Groups say about Pharma's Corporate Reputation | CORPORATE REPUTATION-THE PATIENT PERSPECTIVE | Scoop.it
PatientView's insight:

Nordic patient groups call for greater transparency among pharma

more...
No comment yet.